Disease-directed engineering for physiology-driven treatment interventions in neurological disorders

Area of Science:

• Neuroscience
• Biomedical Engineering
• Translational Medicine

Background:

• Neurological diseases pose significant unmet medical needs, with current treatments lacking curative potential.
• Therapeutic development for neurological conditions is lengthy, costly, and has a high failure rate in late-stage clinical trials.
• Existing approaches often overlook the intricate physiology and pathology crucial for effective intervention.

Purpose of the Study:

• To emphasize the critical need for understanding neurological disease physiology in therapeutic development.
• To guide experimental design and treatment strategies by considering normal physiological and pathophysiological factors.
• To advocate for a systems-level, disease-directed engineering approach for novel neurological interventions.

Main Methods:

• Analysis of normal physiological considerations for experimental design.
• Assessment of pathophysiological factors in acute and chronic neurological diseases for treatment design.
• Case study analysis of a successful nanobased therapeutic intervention incorporating physiological principles.

Main Results:

• A nanobased therapeutic intervention demonstrated successful translation by integrating physiological understanding throughout research.
• Highlighting the importance of a high-level, systems-thinking perspective in designing and administering treatments.
• Demonstrating that a disease-directed engineering approach can enhance therapeutic development outcomes.

Conclusions:

• Embracing the complexity of neurological diseases is essential for advancing treatment development.
• Increased efforts in systems-level thinking are crucial for engineering effective neurological therapeutics.
• Integrating physiological and pathophysiological insights can significantly improve the success rate of neurological disease interventions.